Guinea-Bissau’s minister of health announced Thursday that the country was halting a controversial Danish-led, US-funded trial of a hepatitis B vaccine. The West African country says there are ethical concerns with the study and that the pause is a matter of sovereignty. The World’s Marco Werman learns more about the controversy from Boghuma Titanji (MD), an expert in infectious diseases at Emory University’s School of Medicine.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?